ULBP3 抗体
(UL16 Binding Protein 3 (ULBP3))
Ligand for the NKG2D receptor, together with at least ULBP1 and ULBP2. ULBPs activate multiple signaling pathways in primary NK cells, resulting in the production of cytokines and chemokines. Binding of ULBPs ligands to NKG2D induces calcium mobilization and activation of the JAK2, STAT5, ERK and PI3K kinase/Akt signal transduction pathway. Has lower affinity for NKG2D compared to ULBP1 and ULBP2 and induces weaker signaling responses than does ULBP2 or ULBP1.
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| ULBP3 抗体 | 人 | 兔 Polyclonal |
|
|
|
| ULBP3 抗体 (PE) | 人 | 小鼠 Monoclonal |
|
|
|
| ULBP3 抗体 | 人 | 兔 Polyclonal |
|
|
|
| ULBP3 抗体 (AA 27-216) | 人 | 小鼠 Monoclonal |
|
|
|
| ULBP3 抗体 (Center) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 标记
- PE
- 抗体亚型
- IgG2a
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- Neut (Neutralization: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- MM0594-6E12
- 标记
- unconjugated
- 抗体亚型
- IgG2
- 抗原表位
- AA 27-216
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Center
Latest Publications for our ULBP3 抗体
: "Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro." in: PLoS ONE, Vol. 14, Issue 3, pp. e0212455, (2019) (PubMed).
: "Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function." in: BMC immunology, Vol. 20, Issue 1, pp. 8, (2019) (PubMed).
: "The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy." in: Cell death & disease, Vol. 10, Issue 10, pp. 695, (2019) (PubMed).
: "Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation." in: Journal of cell communication and signaling, Vol. 12, Issue 4, pp. 673-688, (2018) (PubMed).
: "Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells." in: Viruses, Vol. 9, Issue 10, (2017) (PubMed).
: "T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 198, Issue 3, pp. 1172-1182, (2017) (PubMed).
: "Expression and prognostic significance of unique ULBPs in pancreatic cancer." in: OncoTargets and therapy, Vol. 9, pp. 5271-9, (2016) (PubMed).
: "Combination treatment with decitabine and ionizing radiation enhances tumor cells susceptibility of T cells." in: Scientific reports, Vol. 6, pp. 32470, (2016) (PubMed).
: "Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts." in: Blood, Vol. 127, Issue 23, pp. 2879-89, (2016) (PubMed).
: "NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline." in: JCI insight, Vol. 1, Issue 16, pp. e87270, (2016) (PubMed).
: "Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function." in: BMC immunology, Vol. 20, Issue 1, pp. 8, (2019) (PubMed).
: "The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy." in: Cell death & disease, Vol. 10, Issue 10, pp. 695, (2019) (PubMed).
: "Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation." in: Journal of cell communication and signaling, Vol. 12, Issue 4, pp. 673-688, (2018) (PubMed).
: "Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells." in: Viruses, Vol. 9, Issue 10, (2017) (PubMed).
: "T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 198, Issue 3, pp. 1172-1182, (2017) (PubMed).
: "Expression and prognostic significance of unique ULBPs in pancreatic cancer." in: OncoTargets and therapy, Vol. 9, pp. 5271-9, (2016) (PubMed).
: "Combination treatment with decitabine and ionizing radiation enhances tumor cells susceptibility of T cells." in: Scientific reports, Vol. 6, pp. 32470, (2016) (PubMed).
: "Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts." in: Blood, Vol. 127, Issue 23, pp. 2879-89, (2016) (PubMed).
: "NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline." in: JCI insight, Vol. 1, Issue 16, pp. e87270, (2016) (PubMed).
Aliases for ULBP3 抗体
UL16 binding protein 3 (ULBP3) 抗体RAET1N 抗体
您还需要查找其他产品吗？
You are here:
